SBH
AMED

Segall Bryant & Hamill’s Amedisys AMED Stock Holding History

Segall Bryant & Hamill’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,422
Closed -$5.62M – 518
2023
Q2 		$5.62M Sell
61,422
-65,981
-52% -$5.41M 0.06% 320
2023
Q1 		$9.37M Buy
127,403
+2,055
+2% +$178K 0.1% 236
2022
Q4 		$10.5M Sell
125,348
-39,885
-24% -$3.6M 0.12% 213
2022
Q3 		$16M Buy
165,233
+12,082
+8% +$1.44M 0.19% 145
2022
Q2 		$16.1M Buy
153,151
+26,253
+21% +$3.35M 0.18% 149
2022
Q1 		$21.9M Buy
126,898
+13,810
+12% +$2.06M 0.21% 129
2021
Q4 		$18.3M Buy
113,088
+894
+0.8% +$144K 0.17% 149
2021
Q3 		$16.7M Buy
112,194
+19,826
+21% +$4.12M 0.16% 154
2021
Q2 		$22.6M Buy
92,368
+9,698
+12% +$2.54M 0.22% 123
2021
Q1 		$21.9M Sell
82,670
-2,913
-3% -$822K 0.22% 129
2020
Q4 		$25.1M Buy
85,583
+2,013
+2% +$516K 0.28% 99
2020
Q3 		$19.8M Buy
83,570
+38,204
+84% +$8.69M 0.27% 96
2020
Q2 		$9.01M Buy
45,366
+13,261
+41% +$2.47M 0.15% 145
2020
Q1 		$5.89M Buy
32,105
+20,015
+166% +$3.56M 0.12% 168
2019
Q4 		$2.02M Sell
12,090
-1,118
-8% -$166K 0.03% 392
2019
Q3 		$1.73M Buy
13,208
+1,116
+9% +$145K 0.03% 431
2019
Q2 		$1.47M Buy
12,092
+51
+0.4% +$6.05K 0.02% 457
2019
Q1 		$1.49M Buy
12,041
+293
+2% +$36.8K 0.02% 465
2018
Q4 		$1.38M Sell
11,748
-454
-4% -$53.5K 0.02% 465
2018
Q3 		$1.52M Sell
12,202
-10,518
-46% -$1.16M 0.02% 481
2018
Q2 		$1.94M Buy
+22,720
New +$1.67M 0.03% 436

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Segall Bryant & Hamill's AMED Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Amedisys (AMED) in Q3 2023, closing a stake of 61,422 shares — an estimated $5.62M sold.

Segall Bryant & Hamill first reported a position in AMED in Q2 2018 and held it in 21 quarters. The position peaked at $25.1M in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Segall Bryant & Hamill reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 61,422 Amedisys shares in Q3 2023, an estimated $5.62M.
  • Segall Bryant & Hamill first reported a position in Amedisys in Q2 2018 and held it in 21 quarters.
  • Segall Bryant & Hamill's Amedisys position peaked at $25.1M in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.